Evidence map›Paper›PMID 29350338›Full record

ArticleJournal of clinical immunology2018

Reversible Suppression of Lymphoproliferation and Thrombocytopenia with Rapamycin in a Patient with Common Variable Immunodeficiency.

Elissa K Deenick, Adrienne Morey, Mark Danta, Louise Emmett, Keith Fay, Gary Gracie, Cindy S Ma, Rebecca Macintosh, Sandy A B C Smith, Sarah C Sasson and 6 more

Abstract readCase ReportsLetter
PubMed Publisher
In one paragraph

Article in Journal of clinical immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Germline-activating mutations inThe Journal of experimental medicine · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Elissa K DeenickImmunology Division, Garvan Institute of Medical Research, Sydney, Australia.
Adrienne MoreyDepartment of Anatomical Pathology, ACT Pathology, Canberra Hospital, Garran, Canberra, Australia.
Mark DantaSt Vincent's Clinical School, UNSW Sydney, Sydney, Australia.
Louise EmmettDepartment of Nuclear Medicine, St Vincent's Hospital, Sydney, Australia.
Keith FayDepartment of Haematology, Kinghorn Cancer Centre, Sydney, Australia.
Gary GracieDepartment of Anatomical Pathology, St Vincent's Hospital, Sydney, Australia.
Cindy S MaImmunology Division, Garvan Institute of Medical Research, Sydney, Australia.
Rebecca MacintoshSydney Children's Hospital, Randwick, Sydney, Australia.
Sandy A B C SmithSydPath, St Vincent's Hospital, Sydney, Australia.
Sarah C SassonSydPath, St Vincent's Hospital, Sydney, Australia.
William A SewellSydPath, St Vincent's Hospital, Sydney, Australia.
Mark CowleyKinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Darlinghurst, Australia.
Stuart G TangyeImmunology Division, Garvan Institute of Medical Research, Sydney, Australia.
Anthony D KelleherKirby Institute, UNSW Sydney, Sydney, Australia.
CIRCA
Tri G PhanImmunology Division, Garvan Institute of Medical Research, Sydney, Australia. t.phan@garvan.org.au.ORCID 0000-0002-4909-2984

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Common Variable ImmunodeficiencyFemaleHumansImmunoglobulins, IntravenousImmunophenotypingImmunosuppressive AgentsLymphocytesMiddle AgedPositron Emission Tomography Computed TomographySirolimusSymptom AssessmentThrombocytopeniaTreatment OutcomeImmunoglobulins, IntravenousImmunosuppressive AgentsSirolimus

Identifiers

PMID29350338

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.